moxastine
This page covers all moxastine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Histamine H1 receptor.
Targets
Phase 2 pipeline (1)
- Alfadryl · Neuroscience
Alfadryl works by binding to the histamine H1 receptor, blocking the action of histamine and reducing symptoms of allergic reactions.
Patent intelligence
- moxastine patent landscape — aggregated cliff calendar, attackable patents, originator estates